ORTHOPEDIATRICS CORP
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
KIDS$33.48-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity -
| Three and Nine Months Ended September 30, 2024 | ||||||
|---|---|---|---|---|---|---|
| Accumulated | ||||||
| Additional · Other · Total | ||||||
| Common Stock · Paid-in · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Value | Capital | Deficit | Loss | Equity | |
| Balance at January 1, 2024 | 23,378,408 | $6 | $580,287 | $(197,742) | $(5,526) | $377,025 |
| Net loss | — | — | — | (7,805) | — | (7,805) |
| Other comprehensive loss | — | — | — | — | (1,435) | (1,435) |
| Restricted stock | 162,003 | — | 2,799 | — | — | 2,799 |
| Balance at March 31, 2024 | 23,540,411 | $6 | $583,086 | $(205,547) | $(6,961) | $370,584 |
| Net loss | — | — | — | (6,029) | — | (6,029) |
| Other comprehensive loss | — | — | — | — | (3,263) | (3,263) |
| Stock portion of MedTech anniversary payment | 4,288 | — | 133 | — | — | 133 |
| Stock portion of ApiFix anniversary installment | 245,812 | — | 6,929 | — | — | 6,929 |
| Restricted stock | 426,227 | — | 2,939 | — | — | 2,939 |
| Balance at June 30, 2024 | 24,216,738 | $6 | $593,087 | $(211,576) | $(10,224) | $371,293 |
| Net loss | — | — | — | (7,919) | — | (7,919) |
| Other comprehensive income | — | — | — | — | 3,623 | 3,623 |
| Restricted stock | (2,692) | — | 3,922 | — | — | 3,922 |
| Balance at September 30, 2024 | 24,214,046 | $6 | $597,009 | $(219,495) | $(6,601) | $370,919 |
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Three and Nine Months Ended September 30, 2023 | ||||||
|---|---|---|---|---|---|---|
| Accumulated | ||||||
| Additional · Other · Total | ||||||
| Common Stock · Paid-in · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Value | Capital | Deficit | Loss | Equity | |
| Balance at January 1, 2023 | 22,877,962 | $6 | $560,810 | $(176,768) | $(5,400) | $378,648 |
| Net loss | — | — | — | (6,806) | — | (6,806) |
| Other comprehensive loss | — | — | — | — | (646) | (646) |
| Restricted stock | 264,156 | — | 1,959 | — | — | 1,959 |
| Balance at March 31, 2023 | 23,142,118 | $6 | $562,769 | $(183,574) | $(6,046) | $373,155 |
| Net loss | — | — | — | (2,886) | — | (2,886) |
| Other comprehensive loss | — | — | — | — | (1,865) | (1,865) |
| Restricted stock | 14,591 | — | 3,456 | — | — | 3,456 |
| Consideration for MedTech acquisition | 43,751 | — | 2,274 | — | — | 2,274 |
| Stock portion of ApiFix anniversary installment | 140,003 | — | 6,178 | — | — | 6,178 |
| Balance at June 30, 2023 | 23,340,463 | $6 | $574,677 | $(186,460) | $(7,911) | $380,312 |
| Net loss | — | — | — | (4,591) | — | (4,591) |
| Other comprehensive loss | — | — | — | — | (4,255) | (4,255) |
| Stock option exercise | 670 | — | 21 | — | — | 21 |
| Restricted stock | (1,290) | — | 2,364 | — | — | 2,364 |
| Consideration for Rhino | 11,133 | — | 478 | — | — | 478 |
| Balance at September 30, 2023 | 23,350,976 | $6 | $577,540 | $(191,051) | $(12,166) | $374,329 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.